95129 ⎘
Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring; Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring Nitrogen atoms not forming part of a nitro radical
COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
#2AMINOXY ACID-BASED ANTIBACTERIAL COMPOUNDS AND METHODS THEREOF
#3GPX4 INHIBITORS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE FOR TREATING GPX4-MEDIATED DISEASES
#4ANTI-CANCER COMPOUNDS
#5Antagonists of T2R54 and compositions and uses thereof
#6BENZO OXYGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICAL APPLICATION THEREOF
#7CXCR6 SULFONAMIDE COMPOUNDS
#8TEAD INHIBITORS AND USES THEREOF
#9Anti-cancer compounds
#10Antagonists of T2R54 and compositions and uses thereof
#11Immunoregulatory agents
#12Compositions and methods for the treatment of cancer
#13COMPOUNDS AND METHODS FOR HEMATOPOIETIC REGENERATION
#14Anti-cancer compounds
#15Urea motif containing compounds and derivatives thereof as antibacterial drugs
#16Sulfonylureas and related compounds and use of same
#17Compounds and methods for inducing chondrogenesis
#18Compounds and methods of treating or ameliorating an IL-1R-mediated disease or disorder using same
#19Compounds and methods for hematopoietic regeneration
#20Antagonists of the glucagon receptor
#21METHOD FOR COUPLING A FIRST COMPOUND TO A SECOND COMPOUND
#22Immunoregulatory agents
#23Opsin-Binding Ligands, Compositions and Methods of Use
#24Sulfonylaminobenzamide compounds as anthelmintics
#25Oxalic amide ligands, and uses thereof in copper-catalyzed coupling reaction of aryl halides
#26Human GLUT5 specific inhibitors and methods of treatment
#27INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
#28Amination and hydroxylation of arylmetal compounds
#29Compounds and methods of treating or ameliorating an IL-1R-mediated disease or disorder using same
#30Antagonists of the glucagon receptor
#31Sulfonylaminobenzamide compounds as anthelmintics
#32METHOD FOR COUPLING A FIRST COMPOUND TO A SECOND COMPOUND
#33Ortho-alkynyl anilines and process for preparation thereof
#34Modulators of the relaxin receptor 1
#35Complexes
#36Antibacterial agents: Nα-aroyl-N-aryl-phenylalaninamides
#37N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation
#38Inhibitors of human immunodeficiency virus replication
#39Transition-metal-free N-arylation of tertiary amines using arynes
#403-amidobenzamides and uses thereof for increasing cellular levels of A3G and other A3 family members
#41Compounds and methods for inducing chondrogenesis
#42Inhibitors of indoleamine 2,3-dioxygenase (IDO)
#43Antagonists of the glucagon receptor
#44Substituted cyanoguanidines as oral anti-virals
#45Modulators of the relaxin receptor 1
#46Opsin-binding ligands, compositions and methods of use
#472-substituted--quinone derivatives for treatment of oxidative stress diseases
#489-aminomethyl substituted minocycline compounds
#49Compounds and methods for inducing chondrogenesis
#50Methods for treating diabetic complications with carbamoyloxy arylalkanoyl arylpiperazine compounds
#51Apoptosis promoters
#52Antagonists of the glucagon receptor
#53Method for treating pain, anxiety or depression using carbamoyloxy alkanoyl piperazine compound
#54Inhibitors of the shiga toxins trafficking through the retrograde pathway
#55Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease
#56Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's
#57Benzenesulfon amide-compound treatment of a pathological condition linked to an excessive effect of TNF
#58Benzodioxole piperazine compounds
#59Novel compounds which have a protective activity with respect to the action of toxins and of viruses with an intracellular mode of action
#60Indene derivatives as pharmaceutical agents
#61Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease
#62Antagonists of the glucagon receptor
#63EPOXYCARBOXAMIDE COMPOUND, AZIDE COMPOUND, AND AMINO ALCOHOL COMPOUND, AND PROCESS FOR PREPARING a-KETO AMIDE COMPOUND USING THEM
#64Compositions and Methods for Treatment of Cardiovascular Disease
#65N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation
#66Carbamoyloxy arylalkan arylpiperazine analgesics
#67Compositions and methods for the treatment of disease associated with TRP-P8 expression
#68Hydrazonamide compounds that modulate Hsp90 activity
#69Heat Shock Protein 90 Inhibitors, Methods Of Preparing Same, And Methods For Their Use
#70Selective estrogen receptor modulator
#71Aminoquinoline Derived Heat Shock Protein 90 Inhibitors, Methods Of Preparing Same, And Methods For Their Use
#72Apoptosis promoters
#73Inhibitors of the Shiga toxins trafficking through the retrograde pathway
#74Carbamoyloxy arylalkanoyl arylpiperazine analgesics
#75INDENE DERIVATIVES AS PHARMACEUTICAL AGENTS
#76Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease
#77Compounds and compositions for use as modulators of tau aggregation and alleviation of tauopathies
#78Apoptosis promoters
#792-substituted--quinone derivatives for treatment of oxidative stress diseases
#80Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
#81NPY Y5 ANTAGONIST
#82Sirtuin 1 and the treatment of neurodegenerative diseases
#83Indene derivatives as pharmaceutical agents
#84NPY Y5 antagonist
#85Compound capable of inhibiting 17-beta hydroxysteriod dehydrogenase
#86Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
#87Compounds, compositions, and methods for the treatment of synucleinopathies
#88TRIAMINOPYRIMIDINE CYCLOBUTENEDIONE DERIVATIVES USED AS PHOSPHATASE CDC25 INHIBITORS
#89NOVEL CARBAMOYLOXY ARYLALKAN ARYLPIPERAZINE COMPOUND, PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND AND METHOD FOR TREATING PAIN, ANXIETY AND DEPRESSION BY ADMINISTERING THE COMPOUND
#90Indene derivatives as pharmaceutical agents
#919-Aminomethyl Substituted Minocycline Compounds
#92Amide derivatives and medicinal use thereof
#93Selective estrogen receptor modulator
#94Benzamide derivative or salt thereof
#95SULFONYL-SUBSTITUTED BICYCLIC COMPOUNDS AS MODULATORS OF PPAR
#96COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES SUCH AS ALZHEIMER'S DISEASE, TYPE 2 DIABETES, AND PARKINSON'S DISEASE
#97Glucagon Antagonists/Inverse Agonists
#98Use of compounds and compositions for the treatment of amyloid diseases
#99GSK-3 inhibitors
#100Anthranilic acid derivative or salt thereof
#101Novel 8-Sulfonyl-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5HT6 Receptor
#102Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
#103MONOAMIDE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS
#104INHIBITORS OF HISTONE DEACETYLASE
#105Diamine and Iminodiacetic Acid Hydroxamic Acid Derivatives
#106Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same
#107Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives
#108Sulphonamide Derivatives
#109Inhibitors of post-proline cleaving proteases
#110Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of disease
#111Carboxamides and Their Use
#112Epoxycarboxamide compound, azide compound, and amino alcohol compound, and process for preparing α-keto amide compound using them
#113Substituted enaminones, their derivatives and uses thereof
#114Epoxycarboxamide compound, azide compound, and amino alcohol compound, and process for preparing alpha-keto amide compound using them
#115Tetradydro-Naphthalene And Urea Derivatives
#116Ligands for metals and improved metal-catalyzed processes based thereon
#117Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme
#118Amino-methyl substituted tetracycline compounds
#119Sulfonamide compound
#120Compounds, compositions and methods for the treatment of synucleinopathies
#121Novel Biphenyl Compounds And Their Use
#122Compounds, compositions and methods for the treatment of amyloid diseases such as systemic AA amyloidosis
#123Urea derivatives, processes for their preparation, their use as medicaments, and pharmaceutical compositions containing them
#124Carboxylic acid compounds
#125Benzamide derivative or salt thereof
#126Dibenzo[b]perhydroheterocyclic amines and lubricating oil compositions
#127Composition and synthesis of new reagents for inhibition of HIV replication
#128Apoptosis promoters
#129Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
#130Apoptosis promoters
#131NPY Y5 antagonist
#132Topoisomerase inhibitors
#1331,2-di(cyclic) substituted benzene compounds
#134Apparatus for curing a composite laminate
#135Diamino-functional chalcones
#136Sulfonyl-substituted bicyclic compounds as modulators of PPAR
#137Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
#138Selective estrogen receptor modulator
#139Ligands for metals and improved metal-catalyzed processes based thereon
#140Aryl ureido benzoic acid derivatives and their use
#141Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives
#142Amino-functional chalcones
#143Monocyclic aroylpyridinones as antiinflammatory agents
#144Inhibitors of histone deacetylase
#145Substituted aryl thioureas and related compounds; inhibitors of viral replication
#146Compounds derived from aryl carbamates, preparation thereof and uses of same
#147Aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disorders
#148Aminoalkoxy-functional chalcones
#149Glucagon antagonists/inverse agonists
#150N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity
#151Compositions and methods for the treatment of disease associated with Trp-p8 expression
#152Inhibitors of dipeptidyl peptidase IV
#153Substituted arylthiourea derivatives useful as inhibitors of viral replication
#1549-aminomethyl substituted minocycline compounds
#155Amino-methyl substituted tetracycline compounds
#156Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
#157Ubiquitin ligase inhibitors
#158Urea linker derivatives for use as PPAR modulators
#159Indene derivatives as pharmaceutical agents
#160Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
#161N-transfer reagent and method for preparing the same and its application